Evidence map›Paper›PMID 35015288›Full record

ArticleJournal of endocrinological investigation2022

Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.

B Pla Peris, A Á Merchante Alfaro, F J Maravall Royo, P Abellán Galiana, S Pérez Naranjo, M González Boillos

Open access · bronzeAbstract read
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Observational
  7. Review
  8. Article
  9. Review
  10. Review
  11. COVID-19 vaccination and thyroiditis.Best practice & research. Clinical endocrinology & metabolism · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Current concepts regarding Graves' orbitopathy.Journal of internal medicine · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

B Pla PerisDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain. bplaperis@gmail.com.ORCID http://orcid.org/0000-0002-8326-7821
A Á Merchante AlfaroDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain.
F J Maravall RoyoDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain.
P Abellán GalianaDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain.
S Pérez NaranjoDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain.
M González BoillosDepartment of Endocrinology and Nutrition, Hospital General Universitario de Castellón, Avinguda de Benicàssim, 128, 12004, Castelló de la Plana, Castelló, Spain.
Hospital General Universitari de Castelló · ESUniversitat Jaume I · ESUniversidad Cardenal Herrera CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo describe a case series of thyrotoxicosis likely triggered by SARS-CoV-2 vaccination and to warn physicians about this potential correlation. To report clinical, laboratory and imaging findings and provide further information that goes in line with the underlying mechanisms.

methodsSingle-center case series based on all the information collected in the hospital medical records, as well as the temporal sequence between the onset of symptoms and COVID-19 vaccination.

resultsWe report 8 cases with thyrotoxicosis after SARS-CoV-2 vaccination. 4 cases of Graves' disease (GD), 2 cases of subacute painful thyroiditis (SAT), 1 case of concurrent GD and SAT and 1 case of atypical subacute thyroiditis. Five patients received BNT162b2 mRNA vaccine, 3 patients 1273 mRNA vaccine. The onset of symptoms following vaccination ranged from 10 to 14 days in six of eight patients and from 7 to 8 weeks in two patients.

conclusionsSeveral hypotheses have been proposed to explain the potential correlation between SARS-CoV-2 vaccination and thyrotoxicosis, including immune system hyper-stimulation, molecular mimicry and Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA). We should pay greater attention to thyroid disorders in patients receiving vaccine against SARS-CoV-2.

Indexed as

COVID-19Graves DiseaseThyroiditis, SubacuteThyrotoxicosisBNT162 VaccineCOVID-19 VaccinesHumansmRNA VaccinesSARS-CoV-2VaccinationVaccines, SyntheticBNT162 VaccineCOVID-19 VaccinesmRNA VaccinesVaccines, SyntheticAdjuvantsAutoimmune syndromeGraves’ diseaseSARS-CoV-2 vaccinationSubacute painful thyroiditisThyrotoxicosis

Identifiers

PMID35015288
PMCPMC8749352
OpenAlexW4205906395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.